Market Research Logo

Arrhythmias - Pipeline Review, H2 2015

Arrhythmias - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Arrhythmias - Pipeline Review, H2 2015’, provides an overview of the Arrhythmias’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Arrhythmias, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Arrhythmias and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Arrhythmias
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Arrhythmias and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Arrhythmias products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Arrhythmias pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Arrhythmias
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Arrhythmias pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Arrhythmias Overview
Therapeutics Development
Pipeline Products for Arrhythmias - Overview
Pipeline Products for Arrhythmias - Comparative Analysis
Arrhythmias - Therapeutics under Development by Companies
Arrhythmias - Therapeutics under Investigation by Universities/Institutes
Arrhythmias - Pipeline Products Glance
Early Stage Products
Arrhythmias - Products under Development by Companies
Arrhythmias - Products under Investigation by Universities/Institutes
Arrhythmias - Companies Involved in Therapeutics Development
Cynata Therapeutics Limited
Gilead Sciences, Inc.
Nyken BV
Orion Oyj
SciFluor Life Sciences, LLC
SignPath Pharma Inc
Arrhythmias - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Antisense Oligonucleotides to Activate hERG1 for Long-QT Syndrome - Drug Profile
Product Description
Mechanism of Action
R&D Progress
efsevin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
EU-8120 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GS-967 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
KN-93 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NYK-1112 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ORM-10103 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PP-1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Arrhythmia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit CaMKII for Arrhythmias and Heart Failure - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Vesicular Acetylcholine Transporter for Arrhythmias - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Cardiovacular Diseases - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VKII-86 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Arrhythmias - Recent Pipeline Updates
Arrhythmias - Dormant Projects
Arrhythmias - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Arrhythmias, H2 2015
Number of Products under Development for Arrhythmias - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Products under Development by Companies, H2 2015
Products under Investigation by Universities/Institutes, H2 2015
Arrhythmias - Pipeline by Cynata Therapeutics Limited, H2 2015
Arrhythmias - Pipeline by Gilead Sciences, Inc., H2 2015
Arrhythmias - Pipeline by Nyken BV, H2 2015
Arrhythmias - Pipeline by Orion Oyj, H2 2015
Arrhythmias - Pipeline by SciFluor Life Sciences, LLC, H2 2015
Arrhythmias - Pipeline by SignPath Pharma Inc, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Arrhythmias Therapeutics - Recent Pipeline Updates, H2 2015
Arrhythmias - Dormant Projects, H2 2015
Arrhythmias - Discontinued Products, H2 2015
List of Figures
Number of Products under Development for Arrhythmias, H2 2015
Number of Products under Development for Arrhythmias - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report